These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23552735)

  • 41. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.
    Liu S; Marneth AE; Alexe G; Walker SR; Gandler HI; Ye DQ; Labella K; Mathur R; Toniolo PA; Tillgren M; Gokhale PC; Barbie D; Mullally A; Stegmaier K; Frank DA
    Blood Adv; 2018 Dec; 2(23):3428-3442. PubMed ID: 30504235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NR4A transcription factors limit CAR T cell function in solid tumours.
    Chen J; López-Moyado IF; Seo H; Lio CJ; Hempleman LJ; Sekiya T; Yoshimura A; Scott-Browne JP; Rao A
    Nature; 2019 Mar; 567(7749):530-534. PubMed ID: 30814732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
    Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
    Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models.
    He X; Wan J; Yang X; Zhang X; Huang D; Li X; Zou Y; Chen C; Yu Z; Xie L; Zhang Y; Liu L; Li S; Zhao Y; Shao H; Yu Y; Zheng J
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33301426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting NR4A Nuclear Receptors to Control Stromal Cell Inflammation, Metabolism, Angiogenesis, and Tumorigenesis.
    Crean D; Murphy EP
    Front Cell Dev Biol; 2021; 9():589770. PubMed ID: 33634114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
    Karantanos T; Jones RJ
    Adv Exp Med Biol; 2019; 1139():153-169. PubMed ID: 31134500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology.
    Zhao Y; Bruemmer D
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1535-41. PubMed ID: 20631354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-cell analysis of transcription factor regulatory networks reveals molecular basis for subtype-specific dysregulation in acute myeloid leukemia.
    Sun R; Sun L; Xie X; Li X; Wu P; Wang L; Zhu P
    Blood Sci; 2022 Apr; 4(2):65-75. PubMed ID: 35957668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells.
    Beghini A; Corlazzoli F; Del Giacco L; Re M; Lazzaroni F; Brioschi M; Valentini G; Ferrazzi F; Ghilardi A; Righi M; Turrini M; Mignardi M; Cesana C; Bronte V; Nilsson M; Morra E; Cairoli R
    Neoplasia; 2012 Dec; 14(12):1236-48. PubMed ID: 23308055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
    Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear receptor 4A (NR4A) family - orphans no more.
    Safe S; Jin UH; Morpurgo B; Abudayyeh A; Singh M; Tjalkens RB
    J Steroid Biochem Mol Biol; 2016 Mar; 157():48-60. PubMed ID: 25917081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shikonin, a constituent of Lithospermum erythrorhizon exhibits anti-allergic effects by suppressing orphan nuclear receptor Nr4a family gene expression as a new prototype of calcineurin inhibitors in mast cells.
    Wang X; Hayashi S; Umezaki M; Yamamoto T; Kageyama-Yahara N; Kondo T; Kadowaki M
    Chem Biol Interact; 2014 Dec; 224():117-27. PubMed ID: 25451590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia.
    Gong JN; Yu J; Lin HS; Zhang XH; Yin XL; Xiao Z; Wang F; Wang XS; Su R; Shen C; Zhao HL; Ma YN; Zhang JW
    Cell Death Differ; 2014 Jan; 21(1):100-12. PubMed ID: 24076586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
    Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
    Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.
    Högstrand K; Hejll E; Sander B; Rozell B; Larsson LG; Grandien A
    PLoS One; 2012; 7(2):e31366. PubMed ID: 22393362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia.
    Pan Y; Liu D; Wei Y; Su D; Lu C; Hu Y; Zhou F
    Front Pharmacol; 2017; 8():359. PubMed ID: 28659796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia.
    Zhang CC; Yan Z; Pascual B; Jackson-Fisher A; Huang DS; Zong Q; Elliott M; Fan C; Huser N; Lee J; Sung M; Sapra P
    Neoplasia; 2018 Jan; 20(1):1-11. PubMed ID: 29172076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular pathways: the role of NR4A orphan nuclear receptors in cancer.
    Mohan HM; Aherne CM; Rogers AC; Baird AW; Winter DC; Murphy EP
    Clin Cancer Res; 2012 Jun; 18(12):3223-8. PubMed ID: 22566377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammation: a role for NR4A orphan nuclear receptors?
    McMorrow JP; Murphy EP
    Biochem Soc Trans; 2011 Apr; 39(2):688-93. PubMed ID: 21428963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.